--- title: "CBD in a Hemp-Derived World: From Breakout Star to Daily Staple" description: "CBD market in 2025: Discover how hemp-derived products, regulatory uncertainty, and evolving consumer needs are shaping the future of the CBD landscape." image: https://blog.brightfieldgroup.com/hubfs/Canva%20images/CBDHDTHC-1.jpg --- CBD in a Hemp-Derived World: From Breakout Star to Daily Staple 5:56 [![brightfield group logo](https://blog.brightfieldgroup.com/hs-fs/hubfs/BrightfieldGroup_logo_web-02-1.png?width=286&name=BrightfieldGroup_logo_web-02-1.png)](https://www.brightfieldgroup.com/) - [Platform](https://www.brightfieldgroup.com/wellness-cpg-industry-insights) - - [Overview](https://www.brightfieldgroup.com/) - - - Solutions - [Consumer Insights](https://www.brightfieldgroup.com/wellness-cpg-industry-insights) - [Social Listening](https://www.brightfieldgroup.com/social-listening) - [Brand Health](https://www.brightfieldgroup.com/brand-health) - [Custom Research](https://www.brightfieldgroup.com/custom-research) - - Industry - [Wellness CPG](https://www.brightfieldgroup.com/wellness-cpg-industry-insights) - [Hemp Derived THC and CBD](https://www.brightfieldgroup.com/cbd-industry-insights) - [Cannabis](https://www.brightfieldgroup.com/cannabis-industry-insights) - - Role - [Marketing](https://www.brightfieldgroup.com/refine-target-audience#marketing) - [Strategy](https://www.brightfieldgroup.com/refine-target-audience#Strategy) - [Innovation](https://www.brightfieldgroup.com/refine-target-audience#Innovation) - [Finance & Sales](https://www.brightfieldgroup.com/refine-target-audience#Finance-Sales) - [Company](https://www.brightfieldgroup.com/about-us) - - [About Us](https://www.brightfieldgroup.com/about-us) - [Leadership](https://www.brightfieldgroup.com/our-team) - [Methodology](https://www.brightfieldgroup.com/methodology) - [Contact Us](https://www.brightfieldgroup.com/contact-us) - [Blog](https://blog.brightfieldgroup.com/) - [Resources](https://www.brightfieldgroup.com/resources) - [Log In](https://app.brightfieldgroup.com/account/login) [Wellness](https://blog.brightfieldgroup.com/tag/wellness) [CBD](https://blog.brightfieldgroup.com/tag/cbd) [Market Analysis](https://blog.brightfieldgroup.com/tag/market-analysis) # CBD in a Hemp-Derived World: From Breakout Star to Daily Staple ![Matt Zehner](https://blog.brightfieldgroup.com/hubfs/image-6.png) Written by [Matt Zehner](https://blog.brightfieldgroup.com/author/matt-zehner) [![GET OUR LATEST INSIGHTS REPORT](https://no-cache.hubspot.com/cta/default/3989871/1d24366f-eee7-47fe-a712-ab7a6d86d782.png)](https://cta-redirect.hubspot.com/cta/redirect/3989871/1d24366f-eee7-47fe-a712-ab7a6d86d782) Just a few years ago, CBD was everywhere—front and center in wellness stores, splashed across media headlines, and the topic of endless curiosity among consumers. After the 2018 Farm Bill legalized hemp-derived products containing less than 0.3% Delta-9 THC by dry weight, CBD surged into the mainstream. [The market](https://www.brightfieldgroup.com/market-landscape) ballooned with product launches and bold claims, many of which outpaced scientific backing or regulatory clarity. Today, that hype has cooled. As economic conditions, evolving regulations, and new cannabinoid products reshaped consumer interest, CBD has shifted from star player to supporting role. But it hasn’t disappeared. Instead, it’s maturing—integrated more subtly into broader health and hemp categories where its long-term utility is still taking shape. ## Market Momentum: Settling In  ![](https://blog.brightfieldgroup.com/hs-fs/hubfs/image-png-Jul-10-2025-09-51-28-2848-AM.png?width=169&height=164&name=image-png-Jul-10-2025-09-51-28-2848-AM.png)The U.S. CBD industry is emerging from a multiyear contraction that followed its rapid post-Farm Bill expansion. The market faced steep declines in recent years, driven by regulatory limbo at the federal level, difficult economic conditions, shifting consumer preferences, and competition from rising segments like hemp-derived THC. Many brands exited, consolidated, or pivoted during this period, thinning a crowded field. Now, signs of stabilization are starting to emerge. Brightfield Group forecasts 2025 U.S. CBD sales to reach $2.8 billion—including $2.0 billion from non-pharmaceutical products. Public CBD companies have also reported steadier quarter-over-quarter performance, indicating that the worst of the decline may be behind them. That said, growth is unlikely to return in full force without regulatory change. The FDA has yet to provide clear guidelines for CBD in food and dietary supplements, leaving larger retailers and CPG players hesitant to fully engage. Should this change, the market could rebound more meaningfully, with Brightfield Group projecting up to $3.9 billion in total sales by 2030. Without it, CBD’s trajectory will resemble that of a mature category—growing slowly at a projected 1.2% CAGR between 2025 and 2030. ## Finding a Way Through As the industry matures, CBD has increasingly found itself entangled with adjacent markets. Many [wellness-focused brands](https://www.brightfieldgroup.com/wellness-cpg-industry-insights) have reformulated or repositioned their offerings to emphasize functional outcomes, combining CBD with familiar ingredients like melatonin, L-theanine, or ashwagandha to support distinct need states such as sleep, stress, and immunity. Some have even expanded into non-CBD supplements to cater to health-conscious consumers who may not even be familiar with or seeking out cannabinoid products, diversifying their revenue streams. At the same time, CBD has faced competitive pressure from hemp-derived THC products. While many CBD companies initially tried to highlight the differences between [CBD and THC](https://www.brightfieldgroup.com/cbd-industry-insights), there was a segment of CBD consumers that seemed to purchase it because it was the closest thing to legal cannabis that was readily available. ![Did you know (480 x 270 px) (350 x 160 px)-1](https://blog.brightfieldgroup.com/hs-fs/hubfs/Canva%20images/Did%20you%20know%20(480%20x%20270%20px)%20(350%20x%20160%20px)-1.jpg?width=350&height=160&name=Did%20you%20know%20(480%20x%20270%20px)%20(350%20x%20160%20px)-1.jpg)With products containing cannabinoids such as Delta-8, THCA, HHC, and even low dosages of Delta-9 THC increasingly available in gas stations, smoke shops, and even liquor stores, many of these consumers who once used CBD for mild relaxation or other mood-altering outcomes are opting for products that offer more psychoactive effects. For many of these users—especially in states with limited access to legal cannabis—CBD was simply the most accessible option until the rise of hemp THC products. Notably, some of today’s leading hemp THC brands started out as CBD-focused businesses before pivoting. Companies like 3CHI and Hometown Hero initially built their reputations on CBD before shifting attention toward psychoactive hemp derivatives. Meanwhile, many brands still committed to CBD are diversifying their lines, introducing low-dose THC SKUs or hybrid formulas to retain consumers drawn to cannabinoids more broadly.   [![Stay Well, Stay Inspired! Sign up for our Wellness Newsletter and get the latest tips, trends, and expert insights delivered straight to your inbox.  ](https://no-cache.hubspot.com/cta/default/3989871/interactive-189370604334.png)](https://blog.brightfieldgroup.com/hs/cta/wi/redirect?encryptedPayload=AVxigLJL3kHRmcQWkI3pddDlcZBMEQxFDAP95FgXs9jXbRAToLRugS9rApW1o4mV3J3DjQBZQ1K2KoiUHPvVR868265XeELQn%2FNwNfO2c0qz0DCWSsDGfycMz%2BDeelTnxtzihUjh4rqg4dkPR9m1BosfQ3iOIkxHGN5JupCml7v%2FL2mo5M0TAkcEb1O6bcIN88g4JdEiUbAC8IYPuFnISCbwXZ27YVBG4fGqixN8JTR%2FaA%3D%3D&webInteractiveContentId=189370604334&portalId=3989871) ## CBD’s Enduring Appeal Today’s evolving CBD market is defined less by hype and more by consistent, focused usage around key health needs. Brightfield Group’s H1 2025 consumer survey shows a clear throughline in how and why people continue to turn to CBD. Among those who use it, physical relief and sleep are the most sought-after effects, each cited by around 50% of respondents. Relaxation followed closely behind at 46.1%, while all other desired effects fell below 35%.![In-Blog Asset-1](https://blog.brightfieldgroup.com/hs-fs/hubfs/Canva%20images/In-Blog%20Asset-1.jpg?width=600&height=400&name=In-Blog%20Asset-1.jpg) These preferences for restorative and therapeutic effects are reflected in usage patterns. One in three consumers report taking CBD before bed, making it a go-to for winding down. Many (roughly one in five) prefer to use these products when in acute moments of need, with a similar proportion integrating CBD into their daily routines. While CBD may not command the same sales as it did previously, the industry remains sizable and continues to provide valuable relief for many consumers, especially those seeking ways to naturally help their body rest, recover, and regulate. These focused use cases give the category staying power—less as a fad and more as a dependable, functional tool. As long as consumers continue prioritizing restorative care, CBD will have a seat at the table. ## Conclusion: From Fad to Fixture ![Did you know (480 x 270 px) (350 x 160 px)-2](https://blog.brightfieldgroup.com/hs-fs/hubfs/Canva%20images/Did%20you%20know%20(480%20x%20270%20px)%20(350%20x%20160%20px)-2.jpg?width=350&height=160&name=Did%20you%20know%20(480%20x%20270%20px)%20(350%20x%20160%20px)-2.jpg)The CBD market of 2025 isn’t flashy. It’s functional. The category’s strength now lies in consistency, reliability, and integration into wellness behaviors—whether that’s winding down at night, easing tension, or supporting recovery. **As long as consumers prioritize natural self-care, CBD will remain a trusted option**—even if it’s no longer the cannabinoid of the moment. [![Start Running with AI Powered Insights](https://no-cache.hubspot.com/cta/default/3989871/16819bf2-1da9-4f09-acd0-632a7f4293d0.png)](https://cta-redirect.hubspot.com/cta/redirect/3989871/16819bf2-1da9-4f09-acd0-632a7f4293d0) *Updated: 07/10/2025* Close filter ### Get the latest insights with our newsletter! ### Our picks - [Why We Triangulate (And Why That's Just the Beginning)](https://blog.brightfieldgroup.com/why-we-triangulate) - [What Social Data Can’t Tell You About Women’s Wellness (And What Can)](https://blog.brightfieldgroup.com/what-social-data-cant-tell-you-about-womens-wellness-and-what-can) - [The Trend Report Is Dead. Here’s What Should Replace It.](https://blog.brightfieldgroup.com/the-trend-report-is-dead) - [What Women Want Now: The Perimenopause Ingredient Boom](https://blog.brightfieldgroup.com/the-perimenopause-ingredient-boom) - [Beauty from Within: From Collagen to Resveratrol and the Rise of Astaxanthin](https://blog.brightfieldgroup.com/beauty-trends-collagen-astaxanthin) ### Most Recent SOLUTIONS - [Brand Health](https://www.brightfieldgroup.com/brand-health) - [Consumer Insights](https://www.brightfieldgroup.com/consumer-insights) - [Social Listening](https://www.brightfieldgroup.com/social-listening) - [Distribution Trends](https://www.brightfieldgroup.com/distribution-trends) - [Market Landscape](https://www.brightfieldgroup.com/market-landscape) - [Custom Research](https://www.brightfieldgroup.com/custom-research) INDUSTRIES - [Wellness CPG](https://www.brightfieldgroup.com/wellness-cpg-industry-insights) - [Beverages](https://www.brightfieldgroup.com/wellness-cpg-industry-insights) - [Food and Snacks](https://www.brightfieldgroup.com/wellness-cpg-industry-insights) - [Supplements](https://www.brightfieldgroup.com/wellness-cpg-industry-insights) - [Alcohol](https://www.brightfieldgroup.com/wellness-cpg-industry-insights) - [Cannabis](https://www.brightfieldgroup.com/cannabis-industry-insights) - [Hemp Derived THC and CBD](https://www.brightfieldgroup.com/cbd-industry-insights) ROLE - [Marketing](https://www.brightfieldgroup.com/refine-target-audience#marketing) - [Strategy](https://www.brightfieldgroup.com/refine-target-audience#Strategy) - [Innovation](https://www.brightfieldgroup.com/refine-target-audience#Innovation) - [Finance & Sales](https://www.brightfieldgroup.com/refine-target-audience#Finance-Sales) RESOURCES - [Blog](https://blog.brightfieldgroup.com) - [Reports & Guides](https://www.brightfieldgroup.com/resources) - [In the News](https://www.brightfieldgroup.com/news-and-press-brightfield) COMPANY - [About Us](https://www.brightfieldgroup.com/about-us) - [Our Team](https://www.brightfieldgroup.com/our-team) - [Methodology](https://www.brightfieldgroup.com/methodology) - [Privacy Policy](https://www.brightfieldgroup.com/privacy-policy) - [Terms of Service](https://www.brightfieldgroup.com/terms-of-service) - [Contact Us](https://www.brightfieldgroup.com/contact-us) [![BrightFeild Group](https://blog.brightfieldgroup.com/hubfs/BrightfieldGroup_November2019/image/5dcb26208870323275d245f5_BrightfieldGroup_logo_long_WHITE-01.png)](https://www.brightfieldgroup.com/new-site/home) © Copyright 2023 Brightfield Group ```json { "@context" : "https://schema.org", "@type" : "BlogPosting", "author" : { "@type" : "Person", "name" : "Matt Zehner", "url" : "https://blog.brightfieldgroup.com/author/matt-zehner" }, "dateModified" : "2026-06-18T06:58:42.708Z", "datePublished" : "2025-10-14T10:16:27.000Z", "headline" : "CBD in a Hemp-Derived World: From Breakout Star to Daily Staple", "image" : [ "https://blog.brightfieldgroup.com/hubfs/Canva%20images/CBDHDTHC-1.jpg" ], "mainEntityOfPage" : { "@id" : "https://blog.brightfieldgroup.com/cbd-in-a-hemp-derived-world-from-breakout-star-to-daily-staple", "@type" : "WebPage" }, "publisher" : { "@type" : "Organization", "logo" : { "@type" : "ImageObject", "url" : "https://blog.brightfieldgroup.com/hubfs/BrightfieldGroup_logo_DARK_RGB.png" }, "name" : "Brightfield Group" } } ```